Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,610.00
Bid: 1,609.50
Ask: 1,610.00
Change: 5.00 (0.31%)
Spread: 0.50 (0.031%)
Open: 1,610.00
High: 1,618.50
Low: 1,599.50
Prev. Close: 1,605.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Downgrades Zoopla To Equal Weight

Thu, 21st Apr 2016 08:31

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
JEFFERIES RAISES LAND SECURITIES PRICE TARGET TO 975 (957) PENCE - 'HOLD'
----------
JEFFERIES CUTS INTU PROPERTIES PRICE TARGET TO 240 (247) PENCE - 'UNDERPERFORM'
----------
JEFFERIES CUTS HAMMERSON PRICE TARGET TO 473 (493) PENCE - 'UNDERPERFORM'
----------
JEFFERIES CUTS BRITISH LAND PRICE TARGET TO 570 (615) PENCE - 'UNDERPERFORM'
----------
EXANE BNP RAISES GLAXOSMITHKLINE PRICE TARGET TO 1430 (1350) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES GLAXOSMITHKLINE PRICE TARGET TO 1500 (1450) PENCE - 'EQUALWEIGHT'
----------
CITIGROUP RAISES ARM HOLDINGS PRICE TARGET TO 1060 (1045) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES BHP BILLITON PRICE TARGET TO 780 (665) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES SHELL PRICE TARGET TO 2000 (1925) PENCE - 'BUY'
----------
HSBC RAISES BP PRICE TARGET TO 410 (405) PENCE - 'BUY'
----------
GOLDMAN RAISES BUNZL PRICE TARGET TO 1800 (1780) PENCE - 'SELL'
----------
GOLDMAN RAISES RECKITT BENCKISER PRICE TARGET TO 6680 (6640) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES WOLSELEY PRICE TARGET TO 4400 (4300) PENCE - 'BUY'
----------
CHARLES STANLEY RAISES AB FOODS TO 'HOLD' ('REDUCE')
----------
MORGAN STANLEY RAISES SAGE GROUP PRICE TARGET TO 470 (440)P - 'UNDERWEIGHT'
----------
FTSE 250
----------
BARCLAYS CUTS ZOOPLA TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 295 (270) PENCE
----------
PANMURE CUTS AVEVA GROUP PRICE TARGET TO 1864 (1910) PENCE - 'HOLD'
----------
MORGAN STANLEY RAISES AVEVA GROUP TARGET TO 1,240 (1,150)P - 'UNDERWEIGHT'
----------
JEFFERIES CUTS WORKSPACE GROUP PRICE TARGET TO 765 (804) PENCE - 'HOLD'
----------
JEFFERIES RAISES UNITE GROUP PRICE TARGET TO 575 (569) PENCE - 'HOLD'
----------
JEFFERIES RAISES SHAFTESBURY PRICE TARGET TO 888 (801) PENCE - 'HOLD'
----------
JEFFERIES CUTS SEGRO PRICE TARGET TO 380 (414) PENCE - 'HOLD'
----------
JEFFERIES RAISES LONDONMETRIC PROPERTY PRICE TARGET TO 165 (153) PENCE - 'HOLD'
----------
JEFFERIES CUTS HANSTEEN PRICE TARGET TO 110 (115) PENCE - 'HOLD'
----------
JEFFERIES CUTS GREAT PORTLAND PRICE TARGET TO 668 (705) PENCE - 'HOLD'
----------
JEFFERIES CUTS GRAINGER PRICE TARGET TO 215 (240) PENCE - 'HOLD'
----------
JEFFERIES CUTS DERWENT LONDON PRICE TARGET TO 2950 (3055) PENCE - 'HOLD'
----------
JEFFERIES RAISES BIG YELLOW GROUP PRICE TARGET TO 725 (654) PENCE - 'HOLD'
----------
JEFFERIES CUTS PETROFAC TO 'HOLD' ('BUY')
----------
CREDIT SUISSE RAISES SERCO GROUP PRICE TARGET TO 100 (95) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS VICTREX TO 'HOLD' ('BUY') - TARGET 1620 (1800) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.